台股 » 個股 » 台新藥 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

台新藥

(6838)
可現股當沖
  • 股價
    33.65
  • 漲跌
    ▼0.30
  • 漲幅
    -0.88%
  • 成交量
    215
  • 產業
    上市 生技醫療類股
  • 20人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
台新藥 (6838)籌碼相關-凱基-南崁 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/2204/0404/2005/0405/1805/3006/0806/2212/2002/2403/0607/0607/2208/0208/1608/3009/1409/3010/1210/2611/0811/2212/0601/0401/1402/0202/1203/083233343536373839May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

凱基-南崁 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/06134.3000.0033.9512260.44%
2025/03/05134.7000.0034.5012340.43%
2025/02/07235.0000.0034.8522380.84%
2025/02/04634.0300.0034.0562672.25%
2025/02/03133.7500.0034.0512690.37%
2025/01/22234.1000.0034.7522760.72%
2025/01/21234.0800.0034.0522790.72%
2025/01/15134.1000.0034.2512970.34%
2025/01/07134.3500.0035.1013220.31%
2025/01/03137.6000.0037.4013260.31%
2024/12/30137.7000.0037.7013800.26%
2024/12/16138.3500.0038.0015600.18%
2024/12/13139.10139.5539.0005870.00%
2024/12/11639.6000.0039.6066430.93%
2024/12/09139.8000.0039.6017300.14%
2024/12/0600.00240.7040.30-2776-0.26%
2024/12/05241.1000.0040.4527830.26%
2024/11/0500.00146.7546.55-1978-0.10%
2024/11/0100.00145.2545.30-1966-0.10%
2024/10/290.142.9500.0042.600.19680.01%
2024/10/28144.0500.0044.0519650.10%
2024/10/25245.1000.0045.1029750.21%
2024/10/04149.2500.0048.6519560.10%
2024/10/01149.25150.0049.2509350.00%
2024/09/3000.00148.2548.25-1880-0.11%
2024/09/24143.5000.0043.5018410.12%
2024/09/13246.032.245.8646.05-0.2778-0.03%
2024/09/120.141.8500.0041.900.17360.01%
2024/09/110.243.4300.0042.500.27230.02%
2024/09/10345.721.345.8945.501.76940.24%
2024/09/041.137.6500.0037.251.15790.19%
2024/09/030.238.90139.0038.55-0.8573-0.14%
2024/09/02139.3000.0038.9015740.17%
2024/08/29138.8000.0039.5015690.18%
2024/08/15140.2500.0039.9014890.20%
2024/08/14139.9500.0039.5514770.21%
2024/08/13239.5000.0041.9524380.46%
台新藥授權夥伴向瑞士醫療藥品管理局 申請眼科新藥上市查驗登記Anue鉅亨-21天前
〈焦點股〉台新藥眼科新藥出貨至美國展望正向 觸及漲停Anue鉅亨-2024/09/13
〈焦點股〉台新藥眼科新藥9月正式外銷至美國 漲逾半根停板Anue鉅亨-2024/09/06
台新藥 相關文章
台新藥 相關影音